ArticleBMC pediatrics2025
Clinical characteristics and survival outcomes of surgically managed prenatally diagnosed neuroblastoma: a single-center, real-world study.
Article in BMC pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundWith the advancement of ultrasound technology, prenatally diagnosed neuroblastoma (PNB) has become increasingly common. However, knowledge of this particular case remains limited and is usually confined to individual case reports. There is still a lack of research on the clinical characteristics, treatment-related complications, long-term abnormal health problems and quality of life (QoL) of patients with PNB.
methodsThis retrospective study included 49 patients with PNB treated at a tertiary center between 2012 and 2025 and 102 cases from 32 prior studies (total n = 151). Collected data encompassed demographics, tumor characteristics, treatment methods, complications, and survival outcomes. And conduct follow-up evaluations on the patient’s treatment outcome, long-term health status, and QoL.
resultsPNB originated predominantly in the adrenal glands (83.7%), with 63.3% classified as low-risk. Metastasis occurred in 30.6% of cases, primarily involving the liver (80%). MYCN amplification was rare (6.1%), and elevated 24-hour urinary vanillylmandelic acid (VMA) levels were present in only 10.2% of cases. Five-year overall survival (OS) and event-free survival (EFS) rates reached 93.3% and 86.8%, respectively. Survivors had few long-term health problems and QoL scores were comparable to those of healthy children. A comprehensive analysis of 151 patients showed a survival rate of 93.4%, further confirming that PNB has a favorable prognosis.
conclusionThis study is the largest retrospective cohort analysis of PNB to date. It systematically summarizes the clinical characteristics of PNB patients and demonstrates their favorable prognosis and QoL. Furthermore, the findings provide critical evidence to guide risk-stratified management and prenatal counseling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.